Gotu Kola Forms, TECA and Topical Use
Almost every argument about whether gotu kola “works” is really an argument about which gotu kola. A salad leaf in Colombo, a cup of infusion, a 500 mg capsule of milled dried herb, a 60 mg tablet of titrated triterpenic fraction and a Korean cica cream are five different products that happen to share a plant. Only one of them — the titrated fraction — is what the clinical trials studied.
This article is the practical one: what each form contains, what the standardised extract actually is, what doses appeared in the literature, how to read a label, and the two real safety issues — allergic contact dermatitis on the skin, and rare liver injury by mouth.
Table of Contents
- The Forms, and What Each One Delivers
- What TECA and TTFCA Actually Are
- The Name Zoo
- How Well Oral Gotu Kola Is Absorbed
- Doses Used in the Trials
- Topical Use in Practice
- Leaf, Tea and Food Use
- What a Good Label Looks Like
- Contact Dermatitis: the Best-Documented Adverse Effect
- The Liver Reports, in Detail
- Pregnancy, Sedation and Interactions
- Regulatory Status
- Key Research Papers
- Connections
- Featured Videos
The Forms, and What Each One Delivers
| Form | What it is | Triterpene content | Studied? |
|---|---|---|---|
| Fresh leaf | Salad green, juice, sambol | Low and highly variable | As food, not as medicine |
| Dried leaf tea | Infusion of aerial parts | Low; triterpene saponins are poorly water-soluble | No |
| Dried-herb capsule | Milled aerial parts, often 400–500 mg | Unknown unless stated | No |
| Crude extract capsule | Hydro-alcoholic extract, 250–750 mg | Variable; sometimes a stated ratio | The cognition and anxiety studies used this class |
| Titrated extract (TECA / TTFCA) | Purified triterpene fraction, defined composition | Standardised, dosed in mg of fraction | Yes — the venous and scar literature |
| Prescription ointment/powder | TECA in a topical base | Defined | Yes, historically |
| Cosmetic “cica” cream | Centella extract or isolated madecassoside | Usually undeclared, often fractions of a percent | Rarely, and rarely well |
Read down that “Studied?” column and the implication is unavoidable: the effects measured in the trials belong to the titrated extract. Everything else is either food, tradition, or an untested cosmetic dose.
What TECA and TTFCA Actually Are
The titrated extract is a purified fraction rather than a whole-plant extract. Its defining feature is a fixed ratio of three of the plant’s active triterpenes — asiaticoside, asiatic acid and madecassic acid — so that a milligram figure on a box means the same thing from batch to batch.
The classical composition is approximately 40% asiaticoside, with the remainder made up of the two free acids, asiatic acid and madecassic acid, in roughly equal share. Asiaticoside and madecassoside are glycosides — the triterpene core with sugars attached; asiatic and madecassic acid are the corresponding sugar-free cores.
Two abbreviations dominate the literature and they refer to the same kind of material:
- TECA — titrated extract of Centella asiatica. The term used in the French literature and by the plastic-surgery and dermatology papers.
- TTFCA — total triterpenic fraction of Centella asiatica. The term used throughout the Italian vascular literature.
You will also see “titrated extract”, “standardised to total triterpenes”, or a percentage-of-asiaticoside claim on supplement labels. Those phrases are what links a product to the studied material. A product whose only quantitative claim is milligrams of herb says nothing about its triterpene content.
The Name Zoo
The same plant travels under an unusual number of names, which is part of why its literature is hard to follow.
- Botanical: Centella asiatica (L.) Urban. Older literature uses Hydrocotyle asiatica, and older papers file it under Umbelliferae rather than the modern Apiaceae.
- Common: gotu kola, Indian pennywort, Asiatic pennywort, pegaga (Malay), ji xue cao 積雪草 (Chinese), mandukaparni and — contentiously — brahmi (Sanskrit/Hindi).
- Pharmaceutical: a titrated extract of Centella asiatica (TECA) sold as a prescription product in some countries, formulated as ointment, powder, tablet and injection depending on the country and era.
- Cosmetic: “cica”, from cicatrisation (scar formation). An unregulated marketing term that signals nothing about dose.
The name that causes real harm is brahmi, because it is shared with Bacopa monnieri. That has its own article.
How Well Oral Gotu Kola Is Absorbed
This is a fair question for any large saponin, since molecules of that size and polarity often cross the gut wall badly.
Grimaldi and colleagues addressed it directly in 1990, developing an assay for asiatic acid and giving TTFCA to healthy volunteers as single and repeated doses. Twelve volunteers took 30 or 60 mg once, and 30 or 60 mg twice daily for 7 days, in a randomised crossover design. Asiatic acid was measurable in plasma, which establishes that the fraction is orally bioavailable to a useful degree. That is more than most botanicals can demonstrate, and it is one reason the venous trials are worth taking seriously at all — the drug demonstrably reached the circulation. After the week of twice-daily dosing, peak blood levels, total exposure (area under the curve) and half-life of asiatic acid were all significantly higher than after a single dose; the authors explained this by asiaticoside being converted into asiatic acid in the body.
Bioavailability is nonetheless a recognised limitation. The 2022 wound-healing systematic review flagged it explicitly and suggested delivery systems such as nanoencapsulation as a research direction — which is a polite way of saying that getting enough triterpene to the target tissue remains an unsolved formulation problem.
The trials gave the daily dose split two or three times a day rather than all at once (Grimaldi’s volunteers took 30 or 60 mg twice daily). Taking oral gotu kola with food is commonly described as helping the absorption of fat-soluble compounds and reducing stomach upset.
Doses Used in the Trials
| Purpose | Preparation | Dose in the literature | Duration |
|---|---|---|---|
| Chronic venous insufficiency | TECA / TTFCA | 60–180 mg/day, split 2–3 times | 2–8 weeks |
| Diabetic microangiopathy | TTFCA | 120 mg/day (60 mg twice daily) | 12 months |
| Flight-related leg oedema | TTFCA | 180 mg/day around the flight | ~4 days |
| Diabetic wound support | Extract capsule | ~300 mg asiaticoside/day in divided doses | 3 weeks |
| Cognition / mood | Crude extract | 250–1000 mg/day | 6 weeks–2 months |
| Acute startle response | Dried herb | 12 g, single dose — experimental only | Single dose |
| Scars, striae, skin | Topical cream or ointment | Applied twice daily | Weeks to months |
For the venous row, a 2013 systematic review found 8 randomised trials of Centella asiatica in chronic venous insufficiency. Pooling similar studies showed better skin oxygen and carbon dioxide readings (transcutaneous pressures), a slower rate of ankle swelling and a better venoarteriolar response; three trials gave no numbers but reported less leg heaviness, pain and swelling. The authors cautioned that most trials were poorly reported, with an unclear risk of bias (PubMed PMID: 23533507).
Three points about this table. The 12 g startle dose was a one-off supervised experimental dose, not a dose studied for regular use. The cognition doses come from studies whose pooled result was null, so they are “what was tried”, not “what is recommended”. And a dose of titrated fraction is not interchangeable with the same number of milligrams of anything else — 120 mg of TTFCA is not 120 mg of dried leaf.
Topical Use in Practice
Topical is where gotu kola is most used and where the risk–benefit is most favourable: systemic exposure is minimal, so the liver concern essentially disappears, and the indication — skin and scars — is the one the evidence best supports.
Prescription-style products
TECA ointments and powders have been sold as medicines in France, Korea, Japan and parts of southern Europe for decades, for wounds and hypertrophic scars. Where available they contain a declared concentration of the titrated extract, which is what makes them different from a cosmetic.
A 2023 randomised study in Turkey gives a recent example of a declared-strength cream. 280 people who had open carpal-tunnel surgery were split into two groups of 140; one group applied a petroleum-based cream with 1% Centella asiatica extract to the wrist for 6 months after the stitches came out, the other used nothing. At 6 months the cream group had better scar scores (Vancouver Scar Scale), better hand function (QuickDASH score 18.5 against 28.7) and higher satisfaction. The control group had no placebo cream, so the effect of the greasy base itself was not tested (PubMed PMID: 36918311).
Cosmetic cica products
Since around 2015 Centella asiatica has become one of the most-used botanical actives in skincare, typically as extract or isolated madecassoside, sold for redness, barrier repair and post-procedure skin. Points to hold onto:
- Concentration is almost never declared. An ingredient listed near the end of an INCI list may be present at a fraction of a percent.
- “Cica” is a marketing word, not a standard. It guarantees nothing.
- The soothing effect people report is plausible on the anti-inflammatory mechanism, and largely untested at cosmetic doses.
- The base matters as much as the active. Much of the benefit of any barrier cream comes from occlusion and humectants, which the placebo arms of trials also provided.
What Is Known About Using It on Skin
- Patch testing. A home patch test is commonly described: a small amount on the inner forearm daily for five to seven days before use on the face or on a large area. Allergic contact dermatitis to this plant is well documented and builds over days rather than appearing immediately.
- Closed wounds. Scar products are made for fully healed skin. Open, deep, infected or non-healing wounds are treated as a medical problem, not with a botanical cream.
- Time scale. Scar remodelling runs over a year or more. Nothing visible happens in a fortnight.
- What it is compared with. For a new surgical scar, silicone gel or sheeting plus strict sun protection have the best evidence. Centella is usually described as an addition to those rather than a replacement.
- Stinging, itching or redness over successive days. That is the pattern of sensitisation, not of “it’s working”.
Leaf, Tea and Food Use
In Sri Lanka, southern India, Thailand, Malaysia and Indonesia gotu kola is an ordinary vegetable — shredded raw into gotu kola sambol with coconut and lime, blended into cooling green drinks, or cooked into porridge and soups. Culinary quantities have a long, unremarkable history of use.
Two honest caveats. First, food use is not evidence of medicinal effect: nobody has shown that a bowl of sambol does anything measurable to a vein or a scar, and the triterpene dose is far below the studied range. Second, food use is reassuring about ordinary safety at ordinary amounts — which is not the same as safety of a concentrated extract taken daily for months.
Tea deserves a specific note: triterpene saponins are not very water-soluble, so a hot-water infusion extracts them poorly. A gotu kola tea is a pleasant, mild, essentially food-level preparation.
What a Good Label Looks Like
- Centella asiatica printed in full. Not just “brahmi”, not just “gotu kola”.
- Plant part: aerial parts / herb. That is what the pharmacopoeial material and the European Medicines Agency (EMA) monograph cover.
- A standardisation figure — percentage of total triterpenes or asiaticoside, or the words “titrated extract”. Without one, you cannot connect the product to any trial.
- Milligrams of extract, plus the extract ratio (for example 10:1). “1000 mg of gotu kola” with no further detail is a marketing number.
- Third-party testing for identity, heavy metals and microbial contamination. Gotu kola grows in wet ground and standing water and can accumulate contaminants from its growing site — identity and purity testing matters more here than for a cultivated dry-land herb.
- No proprietary “brahmi complex”. Blends make attribution impossible and usually under-dose every component.
Contact Dermatitis: the Best-Documented Adverse Effect
If gotu kola has one well-established harm, this is it, and it belongs to the topical products that most people consider harmless.
The case literature is consistent and spans three decades. Danese and colleagues reported allergic contact dermatitis to Centella asiatica extract in Contact Dermatitis in 1994. Bilbao and colleagues followed in 1995 with a case involving a combination product. Gomes and colleagues reported further cases in 2010. And in 2024 Özkaya and Toprak described two patients in Turkey sensitised to Centella asiatica extract alongside fragrance allergens — showing that the arrival of mass-market cica cosmetics has not made the problem go away. Even the 1979 report on a titrated-extract scar product listed allergic reaction as one of only two adverse effects it observed.
How to recognise it
- Timing: allergic contact dermatitis develops over 24–72 hours after exposure, not within minutes. A product that stings instantly is more likely to be causing irritation than allergy.
- Appearance: itchy redness, small bumps or vesicles, sometimes weeping, confined at first to where the product was applied and later spreading past those edges.
- Course: it recurs and worsens with each re-exposure. Sensitisation is permanent — once allergic, always allergic.
- Confirmation: patch testing by a dermatologist can identify the specific allergen, which matters because it may be the Centella extract or the fragrance, preservative or other botanical in the same jar.
Because the allergen can be the Centella extract or another ingredient, a reaction is identified by formal patch testing; working through products one after another does not separate them, and each re-exposure makes the allergy worse.
The Liver Reports, in Detail
Oral gotu kola has a rare but genuine association with liver injury, and the key report deserves to be described precisely rather than waved at.
Jorge and Jorge, gastroenterologists in Mendoza, Argentina, published three cases in 2005. Three women, aged 61, 52 and 49, developed jaundice after taking Centella asiatica for 30, 20 and 60 days respectively. Their laboratory findings:
- Alanine aminotransferase (ALT) 1193, 1694 and 324 U/L — the first two are dozens of times the upper limit of normal.
- Alkaline phosphatase 503, 472 and 484 U/L.
- Bilirubin 4.23, 19.89 and 3.9 mg/dL.
- The first patient also had anti-smooth-muscle antibody at 1:160 and anti-mitochondrial antibody at 1:320, suggesting an immune-mediated component.
Liver biopsies showed granulomatous hepatitis with marked necrosis and apoptosis in the first patient, chronic hepatitis with cirrhotic transformation and intense necroinflammatory activity in the second, and granulomatous hepatitis in the third. All three improved after stopping the herb, with ursodeoxycholic acid 10 mg/kg/day. The authors noted that the autoantibodies and granulomas point to an immune reaction, and that they “cannot rule out that Centella asiatica discontinuation alone” explains the recovery rather than the ursodeoxycholic acid.
The decisive detail: the first patient took Centella asiatica again and the liver damage recurred. A positive rechallenge is the strongest form of causality evidence in drug-induced liver injury — it is the closest thing to an experiment that clinical practice ever produces. The second patient had also taken the herb a year earlier, consistent with prior sensitisation.
What this does and does not mean
- It is rare. Three cases against very widespread use. Most people take gotu kola without any liver effect, and the trials — including a twelve-month one — reported no such problem.
- It is real. Rechallenge plus biopsy plus recovery on withdrawal is about as solid as a case series gets.
- Duration is the pattern. All three were on continuous daily oral use for weeks. This is the strongest argument for time-limited courses with breaks, which also happens to be traditional practice.
- It applies to oral use. Topical products do not deliver meaningful systemic exposure.
Signs of liver injury are unexplained fatigue, loss of appetite, nausea, right-upper-abdominal discomfort, dark urine, pale stools, itching, and yellowing of the skin or eyes (jaundice); hospitals treat these as urgent. The case reports raise a concern for people with existing liver disease, heavy drinkers and people taking other medicines that can harm the liver. A blood test of liver enzymes is how liver injury is picked up before symptoms appear.
Pregnancy, Sedation and Interactions
- Pregnancy and breastfeeding. There is no safety data for oral use in pregnancy or breastfeeding; the stretch-mark (striae) creams studied in pregnancy were topical and used under trial supervision.
- Sedatives, alcohol and anaesthesia. Gotu kola may add to sedation, which raises a concern alongside benzodiazepines, sleep medication, opioids and alcohol. Herbs with a sedative effect are commonly stopped about two weeks before planned surgery.
- Liver-metabolised medication. Given the hepatotoxicity reports, long-term oral gotu kola together with other drugs that stress the liver adds one liver risk to another.
- Diabetes and lipid medication. There are suggestions of effects on glucose and lipids, so blood sugar and lipid readings may shift in people taking medication for either.
- Allergy: carrot family, not daisy family. Warnings about ragweed, marigold and chrysanthemum are copied from Asteraceae herbs and do not apply. Centella asiatica is Apiaceae — carrot, celery, parsley, fennel.
- Photosensitivity. Sometimes claimed on the basis of the Apiaceae family association with furocoumarins. It is not well documented for this species specifically; sun protection on treated skin is part of standard scar care regardless.
Regulatory Status
The European Medicines Agency’s Committee on Herbal Medicinal Products has finalised its assessment of Centellae asiaticae herba and adopted a European Union herbal monograph, most recently revised in 2022. The therapeutic area the European Medicines Agency files it under is worth noting: skin disorders and minor wounds. Not cognition. Not memory. The European regulator’s own classification matches where the evidence actually is.
Elsewhere:
- France, Korea, Japan and parts of southern Europe: titrated-extract products have been licensed medicines for wounds and scars for decades.
- United States: a dietary supplement. Not approved as a drug, not reviewed for efficacy before sale, and not required to contain what the label says beyond general manufacturing rules.
- Cosmetics generally: Centella asiatica extract and madecassoside are permitted cosmetic ingredients with no efficacy requirement whatsoever.
Key Research Papers
- James JT, Dubery IA. Pentacyclic triterpenoids from the medicinal herb, Centella asiatica (L.) Urban. Molecules. 2009;14(10):3922–3941 — PubMed PMID: 19924039 — The reference account of the four triterpenes, their variability between growing sites, and how extracts are standardised.
- Grimaldi R, De Ponti F, D’Angelo L, Caravaggi M, Guidi G, Lecchini S, et al. Pharmacokinetics of the total triterpenic fraction of Centella asiatica after single and multiple administrations to healthy volunteers. A new assay for asiatic acid. Journal of Ethnopharmacology. 1990;28(2):235–241 — PubMed PMID: 2329813 — Establishes oral bioavailability.
- Brinkhaus B, Lindner M, Schuppan D, Hahn EG. Chemical, pharmacological and clinical profile of the East Asian medical plant Centella asiatica. Phytomedicine. 2000;7(5):427–448 — PubMed PMID: 11081995 — The classic overview of preparations and their clinical use.
- Sun B, Wu L, Wu Y, Zhang C, Qin L, Hayashi M, et al. Therapeutic potential of Centella asiatica and its triterpenes: a review. Frontiers in Pharmacology. 2020;11:568032. — PubMed PMID: 33013406
- Bylka W, Znajdek-Awiżeń P, Studzińska-Sroka E, Brzezińska M. Centella asiatica in cosmetology. Postępy Dermatologii i Alergologii. 2013;30(1):46–49 — PubMed PMID: 24278045 — The review behind the cosmetic use of the extract.
- Bylka W, Znajdek-Awiżeń P, Studzińska-Sroka E, Dańczak-Pazdrowska A, Brzezińska M. Centella asiatica in dermatology: an overview. Phytotherapy Research. 2014;28(8):1117–1124. — PubMed PMID: 24399761
- Arribas-López E, Zand N, Ojo O, Snowden MJ, Kochhar T. A systematic review of the effect of Centella asiatica on wound healing. International Journal of Environmental Research and Public Health. 2022;19(6):3266 — PubMed PMID: 35328954 — Flags bioavailability as the limiting factor.
- Chong NJ, Aziz Z. A systematic review of the efficacy of Centella asiatica for improvement of the signs and symptoms of chronic venous insufficiency. Evidence-Based Complementary and Alternative Medicine. 2013;2013:627182 — PubMed PMID: 23533507 — Eight randomised trials, mostly poorly reported.
- Balevi M, Balevi A. The effect of Centella asiatica cream on scar development in patients who underwent open carpal tunnel release surgery. Journal of Hand Therapy. 2023;36(4):962–966 — PubMed PMID: 36918311 — 280 patients, 1% extract cream against no treatment.
- Jorge OA, Jorge AD. Hepatotoxicity associated with the ingestion of Centella asiatica. Revista Española de Enfermedades Digestivas. 2005;97(2):115–124 — PubMed PMID: 15801887 — Three cases with biopsies and one positive rechallenge.
- Danese P, Carnevali C, Bertazzoni MG. Allergic contact dermatitis due to Centella asiatica extract. Contact Dermatitis. 1994;31(3):201. — PubMed PMID: 7821029
- Bilbao I, Aguirre A, Zabala R, González R, Ratón J, Diaz Pérez JL. Allergic contact dermatitis from butoxyethyl nicotinic acid and Centella asiatica extract. Contact Dermatitis. 1995;33(6):435–436. — PubMed PMID: 8706410
- Gomes J, Pereira T, Vilarinho C, Duarte ML, Brito C. Contact dermatitis due to Centella asiatica. Contact Dermatitis. 2010;62(1):54–55. — PubMed PMID: 20136880
- Özkaya E, Toprak İD. Allergic contact dermatitis from Centella asiatica extract and fragrance allergens: report of two patients from Turkey. Contact Dermatitis. 2024;91(1):85–87 — PubMed PMID: 38567908 — The problem in the cica era.
- Bossé JP, Papillon J, Frenette G, Dansereau J, Cadotte M, Le Lorier J. Clinical study of a new antikeloid agent. Annals of Plastic Surgery. 1979;3(1):13–21 — PubMed PMID: 396846 — A titrated extract of Centella asiatica; notes mild gastric intolerance and allergic reaction as the observed adverse effects.
PubMed Topic Searches
- PubMed: Titrated extract of Centella asiatica (TECA)
- PubMed: Asiatic acid pharmacokinetics and bioavailability
- PubMed: Centella asiatica contact dermatitis and patch testing
- PubMed: Herb-induced liver injury from supplements
- PubMed: Standardisation and asiaticoside content of Centella products
- PubMed: Madecassoside in cosmetic formulation